Dermatoepidemiology

Journal of the American Academy of Dermatology

Volumn 52, Issue 4, 2005, Pages 559-573

  Barzilai, David A ^a,g   Freiman, Anatoli ^b   Dellavalle, Robert P ^c,d   Weinstock, Martin A ^e   Mostow, Eliot N ^a,f  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DERMATOLOGY; DIAGNOSTIC APPROACH ROUTE; EVIDENCE BASED MEDICINE; FAMILY HISTORY; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATIENT MONITORING; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SECONDARY PREVENTION; SKIN CARCINOMA; STATISTICAL ANALYSIS; SUN EXPOSURE; VALIDATION PROCESS;

EID: 17844376486     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.09.019     Document Type: Review

References (121)

1. J. Lind A treatise of the scurvy in three parts, containing an inquiry into the nature, causes and cure of that disease, together with a critical and chronological view of what has been published on the subject 1753 Sands, Murray and Cochran Edinburgh
2. J. Goldberger The etiology of pellagra Public Health Rep 29 1914 1683 1686
3. H.C. Williams Beyond the year 2000: how may epidemiology influence future clinical practice in dermatology? Clin Dermatol 19 2001 55 58
4. R. Marks Dermatoepidemiology: wherefore art thou in this perilous time of need? Int J Dermatol 40 2001 167 168
5. M. Weinstock Dermatoepidemiology Dermatol Clin 13 1995 505 716
6. M.A. Weinstock Validation of a diagnostic test: epidemiologic principles in dermatology Arch Dermatol 125 1989 1260 1264
7. T.Y. Chuang, H.B. Faust, and E.R. Farmer Dermatoepidemiology II: causal inference established by a rule called "associated." Int J Dermatol 36 1997 412 415
8. T.Y. Chuang, G.W. Mirowski, and G.T. Reizner Dermatoepidemiology III: ABC principles for a critical review of the literature Int J Dermatol 37 1998 1 6
9. T.Y. Chuang, and G.T. Reizner Dermatoepidemiology part I: epidemiologic methods Int J Dermatol 32 1993 251 256
10. H. Williams, and D. Strachan The challenge of dermatoepidemiology 1st ed. 1997 CRC Press Boca Raton (FL)
11. Epidemiology Expert Resource Group. Epidemiology curriculum for dermatologists: dermatology, version 1.2. Available from: URL: http://home.cwru.edu/∼dxb69/epi.htm. Accessed October 29, 2004.
12. D.A. Barzilai, R. Mikkilineni, B.R. Davis, S.R. Stevens, and E.N. Mostow Implementation of dermato-epidemiology curriculum at Case Western Reserve University dermatology program Dermatol Online J 10 2004 1
13. R.H. Fletcher, S.W. Fletcher, and E.H. Wagner Clinical epidemiology: the essentials 3rd ed. 1996 LWW Philadelphia
14. H.K. Koh, and A.C. Geller Public health interventions for melanoma: prevention, early detection, and education Hematol Oncol Clin North Am 12 1998 903 928
15. M.M. Chren Dermatologic health services research Dermatol Clin 13 1995 689 695
16. L. Naldi, R. Braun, and J.H. Saurat Evidence-based dermatology: a need to reset the agenda Dermatology 204 2002 1 3
17. R.P. Dellavalle, D.L. Stegner, A.M. Deas, E.J. Hester, M.H. McCeney, and L.A. Crane Assessing evidence-based dermatology and evidence-based internal medicine curricula in US residency training programs: a national survey Arch Dermatol 139 2003 369 372
18. W.H. Clark Jr., L. From, E.A. Bernardino, and M.C. Mihm The histogenesis and biologic behavior of primary human malignant melanomas of the skin Cancer Res 29 1969 705 727
19. H. Williams Introduction to epidemiology and health services research in dermatology R. Champion Rook/Wilkinson/Ebling: textbook of dermatology 6th ed. 1998 Blackwell Science Oxford 139 157
20. S.S. Bhardwaj, F. Camacho, A. Derrow, A.B. Fleischer Jr., and S.R. Feldman Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology Arch Dermatol 140 2004 1520 1523
21. M. Bigby Confidence intervals Arch Dermatol 136 2000 386 387
22. L. Gordis Epidemiology 2nd ed. 2000 WB Saunders Co New York
23. L.A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A. Miller, and L. Clegg SEER cancer statistics review, 1975-2001 2004 National Cancer Institute Bethesda, MD
24. S.C. Chen, J. Yeung, and M.M. Chren Scalpdex: a quality-of-life instrument for scalp dermatitis Arch Dermatol 138 2002 803 807
25. M.M. Chren, R.J. Lasek, L.M. Quinn, E.N. Mostow, and S.J. Zyzanski Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness J Invest Dermatol 107 1996 707 713
26. B. Kirby, D.G. Fortune, M. Bhushan, R.J. Chalmers, and C.E. Griffiths The Salford psoriasis index: a holistic measure of psoriasis severity Br J Dermatol 142 2000 728 732
27. J.L. Sugarman, J.W. Fluhr, A.J. Fowler, T. Bruckner, T.L. Diepgen, and M.L. Williams The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease Arch Dermatol 139 2003 1417 1422
28. S. Burr, and C. Gradwell The psychosocial effects of skin diseases: need for support groups Br J Nurs 5 1996 1177 1182
29. M.M. Chren Understanding research about quality of life and other health outcomes J Cutan Med Surg 3 1999 312 316
30. D.A. Barzilai, M.A. Goodwin, S.J. Zyzanski, and K.C. Stange Does health habit counseling affect patient satisfaction? Prev Med 33 2001 595 599
31. S.R. Feldman, and A.B. Fleischer Jr. Skin examinations and skin cancer prevention counseling by US physicians: a long way to go J Am Acad Dermatol 43 2000 234 237
32. M.A. Weinstock, J.S. Rossi, C.A. Redding, J.E. Maddock, and S.D. Cottrill Sun protection behaviors and stages of change for the primary prevention of skin cancers among beachgoers in southeastern New England Ann Behav Med 22 2000 286 293
33. M.H. Greene The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening Cancer Treat Res 65 1993 103 140
34. P.I. Haigh, L.A. DiFronzo, and D.R. McCready Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis Can J Surg 46 2003 419 426
35. W. Egner The use of laboratory tests in the diagnosis of SLE J Clin Pathol 53 2000 424 432
36. R.A. Eisenberg Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity Springer Semin Immunopathol 14 1992 127 139
37. D.L. Sackett, S.E. Strauss, W.S. Richardson, W. Rosenberg, and R.B. Haynes Evidence-based medicine: how to practice and teach EBM 2nd ed. 2000 Churchill Livingstone Inc New York
38. E. Lidbrink, J. Elfving, J. Frisell, and E. Jonsson Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial BMJ 312 1996 273 276
39. A. Tluczek, E.H. Mischler, B. Bowers, N.M. Peterson, M.E. Morris, and P.M. Farrell Psychological impact of false-positive results when screening for cystic fibrosis Pediatr Pulmonol Suppl 7 1991 29 37
40. M.E. Ming The histopathologic misdiagnosis of melanoma: sources and consequences of "false positives" and "false negatives" J Am Acad Dermatol 43 2000 704 706
41. J.M. Weinberg, E.K. Koestenblatt, W.D. Tutrone, H.R. Tishler, and L. Najarian Comparison of diagnostic methods in the evaluation of onychomycosis J Am Acad Dermatol 49 2003 193 197
42. M. Binder, and S. Dreiseitl The interpretation of test results J Cutan Med Surg 4 2000 19 25
43. C.A. Morton, and R.M. Mackie Clinical accuracy of the diagnosis of cutaneous malignant melanoma Br J Dermatol 138 1998 283 287
44. S.L. Soon, C.O. McCall, and S.C. Chen Computerized digital dermoscopy: sensitivity and specificity aren't enough J Invest Dermatol 121 2003 214 215
45. E.A. Murphey The logic of medicine 1976 Johns Hopkins University Press Baltimore
46. D.L. Sackett Bias in analytic research J Chronic Dis 32 1979 51 63
47. C.Y. Li, and F.C. Sung A review of the healthy worker effect in occupational epidemiology Occup Med (Lond) 49 1999 225 229
48. G.L. Clayman, R.M. Chamberlain, J.J. Lee, S.M. Lippman, and W.K. Hong Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial J Cancer Educ 10 1995 88 90
49. J.A. Shoveller, and C.Y. Lovato Measuring self-reported sunburn: challenges and recommendations Chronic Dis Can 22 2001 83 98
50. S. Gregson, T. Zhuwau, J. Ndlovu, and C.A. Nyamukapa Methods to reduce social desirability bias in sex surveys in low-development settings: experience in Zimbabwe Sex Transm Dis 29 2002 568 575
51. M.K. Salazar Interviewer bias: how it affects survey research AAOHNJ 38 1990 567 572
52. E.L. Wynder Investigator bias and interviewer bias: the problem of reporting systematic error in epidemiology J Clin Epidemiol 47 1994 825 827
53. J.M. Stern, and R.J. Simes Publication bias: evidence of delayed publication in a cohort study of clinical research projects BMJ 315 1997 640 645
54. E.V. Bandera, J.L. Freudenheim, and J.E. Vena Alcohol consumption and lung cancer: a review of the epidemiologic evidence Cancer Epidemiol Biomarkers Prev 10 2001 813 821
55. M. Szklo Confounding and interaction Arch Dermatol 136 2000 1544 1546
56. R.P. Gallagher, J.K. Rivers, T.K. Lee, C.D. Bajdik, D.I. McLean, and A.J. Coldman Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial JAMA 283 2000 2955 2960
57. E.C. Hammond, I.J. Selikoff, and H. Seidman Asbestos exposure, cigarette smoking and death rates Ann N Y Acad Sci 330 1979 473 490
58. V.S. Beltrani The role of house dust mites and other aeroallergens in atopic dermatitis Clin Dermatol 21 2003 177 182
59. D.A. Barzilai, K.D. Cooper, D. Neuhauser, A.A. Rimm, and G.S. Cooper Geographic and patient variation in receipt of surveillance procedures after local excision of cutaneous melanoma J Invest Dermatol 122 2004 246 255
60. S.K. Mattoo, S. Handa, I. Kaur, N. Gupta, and R. Malhotra Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India J Dermatol 28 2001 424 432
61. S.S. Lee, H.Y. Lin, S.R. Wang, C. Tsai, and H.N. Liu Scleroderma after silicone augmentation mammoplasty: report of a case J Formos Med Assoc 93 1994 66 70
62. B. Barankin, D. Shum, and L. Guenther Tumors arising in nevus sebaceus: a study of 596 cases J Am Acad Dermatol 45 2001 792 794
63. W. Korkij, T.Y. Chuang, and K. Soltani Liver abnormalities in patients with lichen planus: a retrospective case-control study J Am Acad Dermatol 11 1984 609 615
64. GISED Lichen planus and liver diseases: a multicentre case-control study BMJ 300 1990 227 230
65. T.Y. Chuang, and G.T. Reizner Bowen's disease and internal malignancy: a matched case-control study J Am Acad Dermatol 19 1988 47 51
66. T.Y. Chuang, J. Tse, and G.T. Reizner Bowen's disease (squamous cell carcinoma in situ) as a skin marker for internal malignancy: a case-control study Am J Prev Med 6 1990 238 243
67. L. Naldi, G. Lorenzo Imberti, F. Parazzini, S. Gallus, and C. La Vecchia Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study Cancer 88 2000 2703 2710
68. A.D. Cohen, M. Friger, B. Sarov, and S. Halevy Which intercurrent infections are associated with maculopapular cutaneous drug reactions? A case-control study Int J Dermatol 40 2001 41 44
69. J.A. Kopec, and J.M. Esdaile Bias in case-control studies: a review J Epidemiol Community Health 44 1990 179 186
70. S.R. Daniels, J.I. Hudson, and R.I. Horwitz Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome J Clin Epidemiol 48 1995 1413 1440
71. H. Heacock, and J. Rivers Assessing scientific data: the case-control study as it applies to dermatology part 1; the case-control method J Cutan Med Surg 1 1997 151 154
72. H. Heacock, and J. Rivers Assessing scientific data: the case-control study as it applies to dermatology part 2; interpreting the results J Cutan Med Surg 2 1997 35 40
73. A.C. Halpern, D. Guerry, D.E. Elder, B. Trock, and M. Synnestvedt A cohort study of melanoma in patients with dysplastic nevi J Invest Dermatol 100 1993 346 349S
74. T.E. Nijsten, and R.S. Stern The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study J Invest Dermatol 121 2003 252 258
75. R.S. Stern, K.T. Nichols, and L.H. Vakeva Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA follow-up study N Engl J Med 336 1997 1041 1045
76. M. Bigby Evidence-based medicine in dermatology Dermatol Clin 18 2000 261 276
77. M. Bigby Odds ratios and relative risks Arch Dermatol 136 2000 770 771
78. O. Gefeller The concept of attributable risk in epidemiology: yesterday, today and tomorrow Stat Methods Med Res 10 2001 157 158
79. M. Bigby, and A.S. Gadenne Understanding and evaluating clinical trials J Am Acad Dermatol 34 1996 555 563
80. J.H. Ware, J.E. Muller, and E. Braunwald The futility index: an approach to the cost-effective termination of randomized clinical trials Am J Med 78 1985 635 643
81. H.C. Williams, and P. Seed Inadequate size of 'negative' clinical trials in dermatology Br J Dermatol 128 1993 317 326
82. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46
83. D.G. Altman Better reporting of randomized controlled trials: the CONSORT statement BMJ 313 1996 570 571
84. M.A. Weinstock The JAAD adopts the CONSORT statement J Am Acad Dermatol 41 1999 1045 1047
85. J.P. Boissel, J.P. Collet, P. Moleur, and M. Haugh Surrogate endpoints: a basis for a rational approach Eur J Clin Pharmacol 43 1992 235 244
86. R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 1989 431 440
87. J.A. Lewis, and D. Machin Intention to treat - who should use ITT? Br J Cancer 68 1993 647 650
88. L.A. Stewart, and M.K. Parmar Bias in the analysis and reporting of randomized controlled trials Int J Technol Assess Health Care 12 1996 264 275
89. A. Britton, M. McKee, N. Black, K. McPherson, C. Sanderson, and C. Bain Choosing between randomized and non-randomized studies: a systematic review Health Technol Assess 2 1998 1 124 i-iv
90. A. Jadad Randomized controlled trials: a user's guide 1st ed. 1998 BMJ Publications London
91. The Evidence-based Medicine Working Group Users' guides to the medical literature: a manual for evidence-based practice 1st ed. 2002 AMA Press Chicago
92. T. Greenhalgh How to read a paper 2nd ed. 2001 BMJ Books London
93. T. Diepgen Public health science in dermatology J. Bolognia J. Jorozzo R. Rapini Dermatology 1st ed. 2003 1959 1968 New York: Mosby
94. K.A. Arndt Information excess in medicine: overview, relevance to dermatology, and strategies for coping Arch Dermatol 128 1992 1249 1256
95. M. Bigby, and H. Williams Appraising systematic reviews and meta-analyses Arch Dermatol 139 2003 795 798
96. T. Greenhalgh How to read a paper: papers that summarize other papers (systematic reviews and meta-analyses) BMJ 315 1997 672 675
97. G. Davey Smith, and M. Egger Meta-analyses of randomized controlled trials Lancet 350 1997 1182
98. M. Egger, and G.D. Smith Meta-analysis: potentials and promise BMJ 315 1997 1371 1374
99. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement; quality of reporting of meta-analyses Lancet 354 1999 1896 1900
100. M. Susser Causal thinking in the health sciences; concepts and strategies of epidemiology 1973 Oxford University Press New York
101. A.B. Hill The environment and disease: association or causation? Proc R Soc Med 58 1965 295 300
102. H.K. Koh, R.A. Lew, and M.N. Prout Screening for melanoma/skin cancer: theoretic and practical considerations J Am Acad Dermatol 20 1989 159 172
103. D.J. Doukas, M. Fetters, M.T. Ruffin, and L.B. McCullough Ethical considerations in the provision of controversial screening tests Arch Fam Med 6 1997 486 490
104. M.J. McQueen Some ethical and design challenges of screening programs and screening tests Clin Chim Acta 315 2002 41 48
105. M. Bigby Snake oil for the 21st century Arch Dermatol 134 1998 1512 1514
106. G.B. Jemec, H. Thorsteinsdottir, and H.C. Wulf Evidence-based dermatologic out-patient treatment Int J Dermatol 37 1998 850 854
107. D. Abeni, C.R. Girardelli, C. Masini, R. Aprea, C.F. Melchi, and P. Puddu What proportion of dermatological patients receive evidence-based treatment? Arch Dermatol 137 2001 771 776
108. M. Bigby Evidence-based medicine in a nutshell: a guide to finding and using the best evidence in caring for patients Arch Dermatol 134 1998 1609 1618
109. H. Williams, K. Adetugbo, A.L. Po, L. Naldi, T. Diepgen, and D. Murrell The Cochrane skin group: preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology Arch Dermatol 134 1998 1620 1626
110. D.L. Sackett, W.M. Rosenberg, J.A. Gray, and R.B. Haynes Evidence based medicine: what it is and what it isn't BMJ 312 1996 71 72
111. N. Scheinfeld Getting started with evidence-based research Dermatol Surg 29 2003 572
112. L. Bero, and D. Rennie The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care JAMA 274 1995 1935 1938
113. G.H. Guyatt, D.L. Sackett, J.C. Sinclair, R. Hayward, D.J. Cook, and R.J. Cook Users' guides to the medical literature IX: a method for grading health care recommendations; evidence-based medicine working group JAMA 274 1995 1800 1804
114. H. Williams Dowling oration 2001: evidence-based dermatology - a bridge too far? Clin Exp Dermatol 26 2001 714 724
115. J. LeLorier, G. Gregoire, A. Benhaddad, J. Lapierre, and F. Derderian Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 1997 536 542
116. J. LeLorier, and G. Gregoire Comparing results from meta-analyses vs large trials JAMA 280 1998 518 519
117. P. Schoenfeld, D. Cruess, and W. Peterson Effect of an evidence-based medicine seminar on participants' interpretations of clinical trials: a pilot study Acad Med 75 2000 1212 1214
118. H. Williams, M. Bigby, T. Diepgen, A. Herxheimer, L. Naldi, and B. Rzany Evidence-based dermatology 2003 BMJ Books London
119. H. Maibach, S. Bashir, and W. Rosser Evidence-based dermatology 1st ed. 2002 BC Decker Inc London
120. D. Abeni, M. Bigby, P. Pasquini, M. Szklo, and H. Williams "Evidence-based dermatology" section in the archives of dermatology Arch Dermatol 136 2000 1552 1553
121. L. Naldi, and J.H. Saurat Dermatology launches the 'evidence-based case report' section Dermatology 205 2002 224 225